The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.
| Date | Payment Type | Form of Payment | Item/Service | Payment Amount | |||||
|---|---|---|---|---|---|---|---|---|---|
| 07/06/2020 | General (Non-Research) | Cash or cash equivalent | Consulting Fee | $235.00 | Details | ||||
|
|||||||||
| 05/05/2020 | General (Non-Research) | Cash or cash equivalent | Consulting Fee | $4935.00 | Details | ||||
|
|||||||||
| 04/08/2020 | General (Non-Research) | Cash or cash equivalent | Consulting Fee | $2820.00 | Details | ||||
|
|||||||||
| 03/05/2020 | General (Non-Research) | Cash or cash equivalent | Consulting Fee | $5170.00 | Details | ||||
|
|||||||||
| 02/10/2020 | General (Non-Research) | Cash or cash equivalent | Consulting Fee | $10026.60 | Details | ||||
|
|||||||||
